Biogen Inc BIIB Price Prediction & Forecast



Forecast

BIIB Stock Price Prediction

Biogen Inc

0%

$0

At close: May 01, 16:00:00 GMT-4

0%

$0

Post-market: May 01, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is BIIB?

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 7,500 full-time employees. The firm is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. The company operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). The company is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. The company also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).

Features

Markets

News

BIIB Stock Price Prediction Summary

BIIB stock price ended at $0 on Sunday, after dropping NaN%

On the latest trading day May 03, 2026, the stock price of BIIB fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for BIIB decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.

BIIB Technical Signals

Technical Signals Summary

Buy Signals 0

Neutral Signals 7

Sell Signals 0

Strong Sell

Sell

Neutral

Buy

Strong Buy

BIIB currently exhibits 0 buy signals and 0 sell signals. The stock has been in an downtrend since --, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.

Bullish/Bearish Signals for BIIB

Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for BIIB. These insights help you make informed investment decisions.

Follow-Up Questions

How do technical analysis indicators apply to BIIB?



According to technical analysis, Biogen Inc has an aggregate signal of Neutral. Biogen Inc has 0 Buy signals, 7 Neutral Signals and 0 sell signals.

What is the RSI for Biogen Inc?



The RSI for Biogen Inc is currently 0, indicating a neutral condition

What is Biogen Inc price for the next 12 months?



Biogen Inc BIIB price for the next 12 months is estimated at $0.

How high is Biogen Inc expected to go?



According to wall street analysts, Biogen Inc is expected to reach a high forecast of $0.

Biogen Inc (BIIB) Stock Price Prediction

BIIB Stock Price Chart